Hormel Foods Corp (HRL US)
HRL US$20.90
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 20.90
- Change
- ▲ 0.29 (1.41)
- Bid / Ask
- 20.89 - 20.91
- Volume
- 965,421
- Turnover
- 18,635,620
- Open
- 20.77
- Day Range
- 20.71 - 20.95
- VWAP
- 20.89
- Prev Close
- 20.61
- Last Trade
- 29/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Consumer Defensive
- Shares Issued
- 550,350,800
- NTA/Share
- 2.44
- Last Dividend
- 0.29
- Dividend Ex Date
- 13 OCT 2026
- Dividend Pay Date
- 16 NOV 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 12,106.16
- EBITDA
- 981.16
- Profit
- 478.20
- Earnings Per Share (EPS)
- 0.87
- Dividend Per Share (DPS)
- 1.16
- Yield %
- 5.68
- Market Cap
- 11,502.33
- Price to Earnings Ratio (P/E)
- 33.71
Estimates (USD) · FY2026
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 12,142.37
- EBITDA
- 1,240.29
- Profit
- 715.70
- Earnings Per Share (EPS)
- 1.37
- Dividend Per Share (DPS)
- 1.17
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- Narrow
- Financial Health
- Moderate
- Uncertainty
- Low
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 23.73 Fair value 25.64 One-star price 27.71
Morningstar Quantitative Rating as of 28 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 25.64
- Price / Fair Value
- 0.80
- Valuation
- Undervalued
- Uncertainty
- Low
Morningstar Quantitative Rating as of 28 OCT 2026. The slider runs from the five-star price (23.73) to the one-star price (27.71).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 20.61 |
| Price - 12 month high | 26.60 |
| Price - 12 month low | 18.97 |
| Pricing date | 27 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 4.69 |
| Market capitalization | 11,342.73 |
| 12 Month High price date | 26 JUN 2026 |
| 12 Month Low price date | 13 OCT 2026 |
| Volume - avg. trading volume for the last 3 months | 5.00 |
| Price - 1 Day % Change | -1.25% |
| Price - 13 week price percent change | -19.37% |
| Price - 26 week price percent change | -3.28% |
| Price - 5 Day % Change | 0.83% |
| Price - 52 week price percent change | -12.85% |
| Price - YTD price percent change | -14.05% |
| Price % Change Month To Date | 3.20% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 0.870 |
| EPS excluding extraordinary items - trailing 12 month | 0.620 |
| EPS Normalized - most recent fiscal year | 1.370 |
| Revenue/share - most recent fiscal year | 21.991 |
| Revenue/share - trailing 12 month | 22.050 |
| Book value per share - most recent fiscal year | 14.363 |
| Book value per share - most recent quarter | 14.252 |
| Book value (tangible) per share - most recent fiscal year | 2.444 |
| Book value (tangible) per share - most recent quarter | 2.578 |
| Cash per share - most recent fiscal year | 1.219 |
| Cash per share - most recent quarter | 1.526 |
| Cash Flow per share - most recent fiscal year | 1.977 |
| Cash Flow per share - trailing 12 month | 1.960 |
| Dividend per share - most recent fiscal year | 1.160 |
| Dividends per share - trailing 12 month | 1.170 |
| EBITD per share - trailing 12 month | 1.553 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 0.870 |
| EPS Basic excluding extraordinary items - trailing 12 month | 0.620 |
| EPS including extraordinary items - most recent fiscal year | 0.870 |
| EPS including extraordinary items - trailing 12 month | 0.620 |
| Free Cash Flow per share - trailing 12 month | 1.396 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 33.24 |
| P/E Normalized, most recent fiscal year | 14.41 |
| Price to sales - most recent fiscal year | 0.93 |
| Price to Tangible Book - most fiscal year | 8.09 |
| Price to Free Cash Flow per Share - most recent fiscal year | 14.76 |
| Price to Cash Flow per share - trailing 12 month | 10.51 |
| Price to Book - most recent fiscal year | 1.45 |
| P/E excluding extraordinary items high, trailing 12 months | 35.56 |
| P/E excluding extraordinary items low, trailing 12 months | 15.54 |
| Net Debt, LFI | 1,986.68 |
| Net Debt, LFY | 2,153.84 |
| Dividend Yield - 5 Year Average | 3.11% |
| Dividend Yield - indicated annual dividend divided by closing price | 5.61% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 5.68% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 942.14 |
| LT debt/equity - most recent fiscal year | 36.01% |
| Payout ratio - most recent fiscal year | 133.33% |
| Total debt/total equity - most recent fiscal year | 36.10% |
| LT debt/equity - most recent quarter | 29.89% |
| Total debt/total equity - most recent quarter | 36.33% |
| Free Cash Flow - trailing 12 month | 769.08 |
| Payout ratio - trailing 12 month | 188.31% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 12,106.16 |
| Revenue - trailing 12 month | 12,146.91 |
| EBITD - most recent fiscal year | 981.16 |
| EBITD - trailing 12 month | 855.60 |
| Earnings before taxes - most recent fiscal year | 663.45 |
| Earnings before taxes - trailing 12 month | 521.90 |
| Net Income available to common - most recent fiscal year | 478.20 |
| Net Income available to common - trailing 12 months | 342.71 |
| Earnings before taxes Normalized - most recent fiscal year | 756.59 |
| Net Income Available to Common, Normalized - most recent fiscal year | 754.61 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 1.43 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 3.95% |
| Net Profit Margin % - trailing 12 month | 2.82% |
| Operating margin - 1st historical fiscal year | 7.39% |
| Operating margin - trailing 12 month | 6.56% |
| Pretax margin - trailing 12 month | 4.30% |
| Pretax margin - 1st historical fiscal year | 5.48% |
| Operating Margin - 5 year average | 8.88% |
| Pretax Margin - 5 year average | 8.54% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 7.78% |
| Free Operating Cash Flow/Revenue, TTM | 6.33% |
| Net Profit Margin - 5 year average | 6.65% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 3.56% |
| Return on average assets - trailing 12 month | 2.56% |
| Return on average equity - most recent fiscal year | 5.97% |
| Return on average equity - trailing 12 month | 4.31% |
| Return on average assets - 5 year average | 6.00% |
| Return on average equity - 5 year average | 10.37% |
| Net Income/employee - most recent fiscal year | 23,888.20 |
| Revenue/employee - most recent fiscal year | 605,308.00 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 4.73% |
| EPS growth rate, 5 year | -12.12% |
| Growth rate% - dividend, 3 year | 3.71% |
| Revenue/share (5 yr growth) | 4.58% |
| Growth rate% - Revenue, 3 year | -0.95% |
| Growth rate% - EPS, 3 year | -21.81% |
| Book value per share growth rate, 5 year | 3.83% |
| Capital Spending growth rate, 5 year | -3.29% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | -5.56% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | |||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | OCT 21 | OCT 22 | OCT 23 | OCT 24 | OCT 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and became a branded food company. The firm sells its wares through multiple channels, including US retail (61.6% of fiscal 2025 sales), US foodservice (32.6%), and international (less than 6%). By product, 73% of fiscal 2025 sales were from perishable food and 27% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy. Many of these hold the number one or two market share in their respective categories.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
